Hirtle Callaghan & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$86.7M |
| 2 |
Philip Morris
PM
|
+$77.6M |
| 3 |
Altria Group
MO
|
+$31.1M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$21.6M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Community Health Systems
CYH
|
+$110K |
| 2 |
HealthStream
HSTM
|
+$16.3K |
| 3 |
PACCAR
PCAR
|
+$12.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.38% |
| 2 | Financials | 7.1% |
| 3 | Energy | 6.16% |
| 4 | Healthcare | 4.27% |
| 5 | Technology | 4.21% |
Similar funds
Hirtle Callaghan & Co's Q3 2013 Portfolio in Review
As of Q3 2013, Hirtle Callaghan & Co held 713 positions worth $619M, up 7,069% from $8.64M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Hirtle Callaghan & Co deployed $607M of net new capital in Q3 2013, opening 622 new positions and adding to 43 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.
By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 17% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was HealthStream, an estimated $16.3K trimmed.
- Hirtle Callaghan & Co's largest Q3 2013 buy was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.
- Hirtle Callaghan & Co added most to Philip Morris in Q3 2013, an estimated $77.6M increase.
- Hirtle Callaghan & Co's biggest Q3 2013 reduction was HealthStream, cutting an estimated $16.3K.
- Hirtle Callaghan & Co fully exited Community Health Systems in Q3 2013, selling an estimated $110K.
- Hirtle Callaghan & Co's ten largest holdings make up 55% of its $619M portfolio in Q3 2013.
- Hirtle Callaghan & Co opened 622 new positions and closed 4 in Q3 2013.
- Hirtle Callaghan & Co's portfolio value rose 7,069% quarter-over-quarter to $619M.
Based on Hirtle Callaghan & Co's 13F filing for Q3 2013, filed 12 Nov 2013.